Top Markets
Coin of the day
Neovacs S.A. Neovacs S.A.

Neovacs S.A.

ALNEV
Clasificación en acciones #21228
Neovacs S.A., a biotechnology company, focuses on the development of... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Precio por acción
$0.00047446
Capitalización bursátil
$82.80
Cambio (1 día)
0.00%
Cambio (1 año)
-98.16%
País
FR
Comercio Neovacs S.A. (ALNEV)

Categoría

EPS de Neovacs S.A. (ALNEV)
EPS a fecha de December 2024 TTM: $-34.55K
Según los últimos informes financieros y el precio de las acciones de Neovacs S.A., el EPS actual de la empresa (TTM) es $-34.55K. Al final del año 2023, la empresa tenía un EPS de $-275.26K un aumento con respecto a al EPS de 2022, que fue de $-1.26.
Historial de EPS de Neovacs S.A. desde 2007 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $-34.55K 17,504.17%
2024 $-196.26 -99.93%
2023 $-275.26K 21,820,011.06%
2022 $-1.26 -100.00%
2021 $-5.367T -93.96%
2020 $-88.856T -79.32%
2019 $-429.767T -54.85%
2018 $-951.868T -52.78%
2017 $-2.02Qa -24.26%
2016 $-2.66Qa 115.81%
2015 $-1.23Qa -59.95%
2014 $-3.08Qa -17.40%
2013 $-3.73Qa -18.52%
2012 $-4.58Qa -9.86%
2011 $-5.08Qa -27.43%
2010 $-6.99Qa 21.97%
2009 $-5.73Qa 53.05%
2008 $-3.75Qa -7.11%
2007 $-4.03Qa 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$3.62 -100.01%
DK
$15.47 -100.04%
US
$43.12 -100.12%
US
$9.62 -100.03%
BE
$38.32 -100.11%
NL